Integra LifeSciences Holdings Corporation
DE ˙ DB ˙ US4579852082
13,30 € ↓ -0,40 (-2,92%)
2026-06-02
DEL PRIS
SecurityDE:IL3 / Integra LifeSciences Holdings Corporation
InstitutionInvesco Ltd.
Latest Disclosed Ownership3,490,908 shares
Ownership 4.50%
Invesco Ltd. ownership in IL3 / Integra LifeSciences Holdings Corporation

2025-11-06 - Invesco Ltd. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,490,908 shares of Integra LifeSciences Holdings Corporation (DE:IL3). This represents 4.5 percent ownership of the company. In their previous filing dated 2025-05-09 , Invesco Ltd. had reported owning 4,111,700 shares, indicating a decrease of -15.10 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2025-11-06 2025-11-06 13G/A 4,111,700 3,490,908 -15.10 4.50 -15.09
2025-05-09 2025-05-09 13G 4,111,700 5.30

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,485,603 -37,236 -1.06 32,834 -24.96 0.0006
2026-02-19 2025-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,522,839 31,931 0.91 43,754 -12.54 0.0067
2025-11-13 2025-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,490,908 -46,299 -1.31 50,025 15.26 0.0079
2025-08-13 2025-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,537,207 106,577 3.11 43,402 -42.47 0.0074
2025-05-12 2025-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,430,630 1,364,345 66.03 75,440 60.98 0.0143
2025-02-13 2024-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,066,285 -4,772 -0.23 46,863 24.53 0.0087
2024-11-12 2024-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,071,057 43,430 2.14 37,631 -36.31 0.0073
2024-08-13 2024-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,027,627 1,625,373 404.07 59,085 314.37 0.0125
2024-05-14 2024-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 402,254 236,375 142.50 14,260 97.38 0.0031
2024-02-13 2023-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 165,879 1,954 1.19 7,224 15.40 0.0017
2023-11-13 2023-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 163,925 -11,703 -6.66 6,260 -13.33 0.0017
2023-08-11 2023-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 175,628 2,459 1.42 7,224 -27.34 0.0019
2023-05-12 2023-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 173,169 -40,489 -18.95 9,942 -17.01 0.0028
2023-02-13 2022-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 213,658 44,570 26.36 11,980 67.23 0.0035
2022-11-14 2022-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 169,088 -12,527 -6.90 7,163 -26.99 0.0023
2022-08-15 2022-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 181,615 20,667 12.84 9,811 -5.14 0.0030
2022-05-16 2022-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 160,948 5,623 3.62 10,343 -0.60 0.0026
2022-02-14 2021-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 155,325 -5,090 -3.17 10,405 -5.28 0.0025
2021-11-15 2021-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 160,415 7,493 4.90 10,985 5.27 0.0028
2021-08-17 2021-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 152,922 -253,173 -62.34 10,435 -62.81 0.0026
2021-05-17 2021-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 406,095 -100,122 -19.78 28,057 -14.63 0.0075
2021-02-16 2020-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 506,217 -82,136 -13.96 32,864 18.29 0.0096
2020-11-16 2020-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 588,353 -50,159 -7.86 27,782 -7.41 0.0094
2020-08-14 2020-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 638,512 505,986 381.80 30,004 406.82 0.0107
2020-05-15 2020-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 132,526 37,731 39.80 5,920 7.15 0.0025
2020-02-14 2019-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 94,795 -1,090,058 -92.00 5,525 -92.24 0.0017
2019-11-14 2019-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,184,853 -39,741 -3.25 71,174 4.06 0.0186
2019-08-14 2019-06-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,224,594 18,505 1.53 68,394 1.77 0.0176
2019-08-14 2019-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,224,594 -1,200,199 68,394
2019-05-15 2019-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,206,089 -2,650 -0.22 67,203 23.28 0.0227
2019-02-14 2018-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,208,739 66,005 5.78 54,514 -27.58 0.0209
2018-11-14 2018-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,142,734 10,273 0.91 75,272 3.19 0.0237
2018-08-14 2018-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,132,461 -264,815 -18.95 72,942 -5.67 0.0241
2018-05-15 2018-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,397,276 -75,657 -5.14 77,325 9.69 0.0289
2018-02-14 2017-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,472,933 -102,349 -6.50 70,495 -11.35 0.0254
2017-11-14 2017-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,575,282 -28,480 -1.78 79,521 -9.04 0.0294
2017-08-14 2017-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,603,762 4,937 0.31 87,421 29.79 0.0272
2017-05-15 2017-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,598,825 798,708 99.82 67,358 -1.87 0.0221
2017-02-14 2016-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 800,117 616,713 336.26 68,642 353.38 0.0231
2016-11-14 2016-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 183,404 21,872 13.54 15,140 17.48 0.0052
2016-08-15 2016-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 161,532 58,421 56.66 12,887 85.53 0.0047
2016-05-16 2016-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 103,111 -8,481 -7.60 6,946 -8.17 0.0028
2016-02-16 2015-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 111,592 7,392 7.09 7,564 21.90 0.0030
2015-11-16 2015-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 104,200 12,140 13.19 6,205 0.05 0.0026
2015-08-14 2015-06-30 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 92,060 9,037 10.88 6,202 21.16 0.0024
2015-05-15 2015-03-31 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 83,023 5,112 6.56 5,119 21.16 0.0020
2015-02-13 2014-12-31 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 77,911 -720,302 -90.24 4,225 -89.34 0.0016
2014-11-14 2014-09-30 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 798,213 1,964 0.25 39,623 5.74 0.0158
2014-08-14 2014-06-30 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 796,249 -7,010 -0.87 37,472 1.43 0.0147
2014-05-15 2014-03-31 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 803,259 9,916 1.25 36,942 -2.40 0.0150
2014-02-13 2013-12-31 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 793,343 11,279 1.44 37,850 20.24 0.0150
2013-11-13 2013-09-30 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 782,064 172,456 28.29 31,478 40.97 0.0137
2013-08-14 2013-06-30 13F INTEGRA LIFESCIENCES HOLDING COMMON 457985208 609,608 609,608 22,330 0.0104
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.